Trial Profile
A Real World Study of Efficacy and Safety for Apatinib Treatment as the Neoadjuvant Therapy in Advanced Colorectal Cancer
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Sep 2020
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Colon cancer; Colorectal cancer; Liver metastases; Rectal cancer
- Focus Therapeutic Use
- 28 Dec 2017 New trial record